Company Filing History:
Years Active: 2009
Title: Erin E Brachman: Innovator in Genetic Information Alteration
Introduction
Erin E Brachman is a prominent inventor based in Newark, Delaware. She has made significant contributions to the field of genetic engineering, particularly in the area of nucleic acid sequence alteration. Her innovative work has the potential to enhance the efficiency of genetic modifications, which can have far-reaching implications in biotechnology and medicine.
Latest Patents
Erin E Brachman holds a patent for her invention titled "Enhanced oligonucleotide-mediated nucleic acid sequence alteration." This invention focuses on the oligonucleotide-mediated repair or alteration of genetic information. It includes methods, compositions, and kits designed to improve the efficiency of such alterations. The invention utilizes factors such as Histone Deacetylase Inhibitor (HDAC), Lambda phage beta protein, and hydroxyurea to achieve enhanced efficiency in genetic modifications.
Career Highlights
Brachman is affiliated with the University of Delaware, where she continues to advance her research in genetic engineering. Her work is characterized by a commitment to innovation and a desire to push the boundaries of what is possible in the field of genetics.
Collaborations
Erin E Brachman collaborates with notable colleagues, including Eric B Kmiec and Hetal Parekh-Olmedo. These partnerships enhance her research efforts and contribute to the development of groundbreaking technologies in genetic alteration.
Conclusion
Erin E Brachman is a trailblazer in the field of genetic information alteration, with a focus on enhancing the efficiency of nucleic acid modifications. Her contributions are paving the way for future advancements in biotechnology and medicine.